Adverse drug events (ADEs) are a major limitation of drug safety. They are often caused by inappropriate selection of dose and the concurrent use of drugs modulating each other (drug interaction). Risk assessment and prevention strategies must therefore consider co-administered drugs, individual doses, and their timing. In a new approach we evaluated the performance of cross correlation, commonly used in signal processing, to determine similarities in patient treatments. To achieve this, patient treatments were modeled as groups of vectors representing discrete time intervals. These vectors were cross-correlated and the results evaluated to find clusters in time courses indicating similarity in treatment of different patients. To evaluate our algorithm, we then created a number of test cases. The focus of this article is on each treatment and its pattern in time and dosage. The algorithm successfully produces a relatively low similarity score for cases that are completely different with respect to their pattern of time and dosage but high scores when they are equal (score of 0.699) or similar (score of 0.528) in their therapies and thus succeeds in having a relatively high specificity (27/30). Such an approach might help to considerably reduce the problem of false alarms which hampers most existing alerting systems for medication errors or impending ADEs.
Introduction
Adverse drug events (ADEs) are a major factor limiting safety and effectiveness of drug therapy in modern health care systems. For example in the USA an estimated 770,000 people are subject to an ADE during their stay in a hospital and about 140,000 of them die because of it [1] . The estimated annual costs are about $4 billion, of which about half may be avoidable [2] . Although not studied thus far there is no evidence to suggest that the problem is much different or substantially smaller in Germany. However, there have been some efforts in the last years to overcome this drawback [3 -5] . Computerized physician order entry systems (CPOE), barcode identification, and automated dosing systems have been introduced to reduce the errors inherent to the process of administering medication (from the prescription process to dispensing) like misspelling, misreading, and confusion of medication or patient data. Another effective option is to support the physician during the prescription process with pertinent information and decision support on medical therapy [6] . This is the focus of this paper.
It is a common approach to warn the practitioner while he is entering the intended medication for a patient if there is an assumed adverse interaction with another drug or with the patient's state of health. This alert process is normally aided by the use of databases containing lists of interactions or other known risk situations [7] . Standard practice entails the computer to issue warnings to the user if the patient has drug X or condition Y (e.g. allergy) in the presence of which drug Z is known to likely cause an ADE. However, the specificity of such alert systems is limited because potentially harmful drug combinations do not result in an ADE in all instances. This leads conventional warning systems to issue many false alarms. These warning systems have a rather good sensitivity but their poor specificity prompts practitioners to ignore them [8, 9] or to override alerts [10, 11] . The aim of this ongoing research is to develop an electronic drug prescription system, which more selectively identifies risks associated with drug therapy, with more specific alerts and therefore better acceptance than the current systems. The proposed algorithm may be a key element in such a system since it will directly influence its user-friendliness.
Background
In most medical specialties the occurrence of ADEs is a complex process and the circumstances leading to a particular event are not always known in detail. While it is often possible to retrospectively identify an ADE it is much more difficult to point out exactly what leads to it, especially considering individual variability of important pharmacologic processes between different patients [12, 13] . In such a relatively uncertain domain it is challenging to form sets of clear rules that identify ADEs. Therefore, case similarity suggests itself as an approach that may circumvent the problems of characterizing ADEs through sets of rules.
2.1Introduction to case based reasoning (CBR)
CBR is a sub-discipline of artificial intelligence that is based on the assumption of analogy. The main theorem of CBR is that if two problems are similar their solutions also are. The mechanics are therefore that a pool of problems and their respective solutions within a certain domain is collected. If then a new problem arises the pool is searched for the most similar problem. The solution of this already solved problem is then applied to the new problem at hand. The solution of the old problem may have to be slightly modified to the new needs ( Figure  1 ). CBR has some intriguing advantages. First it works well in domains where the knowledge is relatively rudimentary. Second, in order to build a system it is not necessary to query experts about their way of reasoning. Rather records of old cases such as progress notes or standardized charts can be used. Third it is easy to add new knowledge in the form of new cases or to adapt existing ones and, therefore, fourth, it is simple to manage and maintain an up-to-date base of knowledge [14] . In our system we want to collect a reference base of detailed medical cases with verified ADEs. If a new case arises in practice with striking similarity to a case in the database, then the system should alert the practitioner. One problem with this approach is the complexity of modeling time elapsed and temporal interrelationships between exposure with different drugs and concurrently developing events. Most drug effects do not only depend on pharmacodynamics but are time dependent and often related to pharmacokinetics. Therefore, the temporal relationships between drug exposure of a patient and events are essential to assume similarity in different cases. An earlier approach using CBR and temporal abstraction [15] made it possible to cover the feature space of a problem with a fixed set of predictable states this problem can reach. Therefore a case modeling of problems was developed which consists of a distribution of different states over time. This is only possible if a predefined set of attributes with conceivable value ranges can directly be mapped to the set of medical states. Obviously it is not possible to predefine every possibly occurring medical state during treatment. Therefore we aimed to find a different case modeling and similarity measure.
Introduction to cross correlation
We took a new approach in using cross-correlation to determine similarities in treatments. In signal processing, the cross-correlation function is commonly used to determine similarities between two time dependent signals. To determine cross-correlation between two signals we first have to define the correlation between data in general. Correlation between two groups of data implies that they move or change with respect to each other in a structured way. The correlation coefficient is an indicator for the strength and sense or direction of correlation. For N pairs of data (x, y) the correlation coefficient is calculated thus
The 'active part' of equation (1) is the enumerator summation which tends to zero if there is little common movement between x and y and approaches high positive and negative values depending on whether x and y tend to move together or in opposite senses. The denominator terms merely have a normalizing effect which delimits the range of the correlation coefficient to [-1,1] [16] . The correlation coefficient can be used to determine correlation between two sets of data. When measuring the correlation between two signals from two time series of discrete numbers it is possible that two signals may have common components but different timing. The cross-correlation function (equation (2)) is that function which is formed from successive values of the correlation coefficient taken at time shifts k = 1, 2, … n data sampling intervals. Different approaches are available to insert y values where the formula would reach beyond the interval covered through recorded values.
The time shift at which the correlation coefficient reaches its highest value indicates the relative position in time where both signals are closest correlated. Therefore the cross-correlation function can be used to identify simple time delays between events in two signals. [17] 
Design considerations and system description

Definition of terms
For the development of the model and the similarity algorithm the following terminology has been applied (1) A treatment is the information about a distinct therapy with an active compound of a drug administered to a patient during his hospitalization (e.g. the fact of giving him aspirin). (2) A time and dosage pattern is the chronological information about dose and dosing interval of a treatment (e.g. every day one 10mg tablet in the morning and two 10mg tablets in the evening). (3) A course of treatment is the information of a treatment (1) combined with the corresponding time and dosage pattern (2) . (4) A case is the set of all courses of treatment (3) one patient receives during his stay. This information is used equivalent to a CBR case.
Case modeling
Our modeling of cases is simple. For each treatment, the model includes an identifier for the treatment, as well as a vector for the time and dosage pattern which consist of slots for discrete points in time where a treatment could have taken place and the particular dose that was given then (Figure 2 ). Per day, there are five time slots for drug administration (morning, noon, evening, bedtime, and night) in the present version of the model.
Traditional approach
A common approach to compare two different cases of two different patients would be to count the number of medically equivalent treatments (e.g. both patients received some sort of aspirin product). This is done by interleaving two list searches as described earlier [18] . Depending on the number of equivalent and different treatments in both cases, a similarity score can be determined according to Algorithm 1 ( Figure 3 ). Because this algorithm omits the chronological information when those treatments occurred (e.g. two tablets in the morning and two in the evening) we call it a 'no time' algorithm.
New algorithm
In medicine, chronological information is an important element for judging the equivalence of different cases. For this reason we enhanced the 'no time' algorithm by correlating the time and dosage pattern of a treatment in one case with the time and dosage pattern of the equivalent treatment in another case. The presented time sensitive similarity algorithm consists of four sub-algorithms which are explained below. In the first steps our algorithm does not differ from the 'no time' algorithm. We have two patient encounters and want to determine how similar they are in respect to their cases, which is achieved by comparison of the lists of treatments in both cases. Every pair of medically equivalent treatments from each case is marked and put aside in a separate list. The number of equivalent treatments is divided by the overall number of treatments. This number determines the first half of the similarity score (Algorithm 1 / Figure 3) . In this first part of the algorithm we want to ensure that the model's similarity score accounts for both similarities and discrepancies. Cases that have matching pairs in two of thirty treatments should not be rated too similar even if these two have a very similar pattern in time because we aim to assess the general similarity of two cases in respect to their whole courses of drug therapy. Next, the time and dosage pattern comparison begins. The temporal part of each course of treatment in each pair is cross-correlated. The result is a number that is subsequently normalized to a score between 0 and 1. As we are not interested in negative correlation 0 is assigned if formula (2) delivers a negative value. The correlation is calculated for every possible step of the time scale (Figure 4 ). The highest score indicates the relative distance in time where both time and dosage patterns have the highest similarity. This score is stored together with the corresponding relative time shift. The resulting process creates a list of treatments, their corresponding similarity scores, and the corresponding time lag at which the similarity occurred (Algorithm 2). In the next step the algorithm parses this list for the relative position in time around which most of the high scores gather. It steps through the list building up a histogram over all possible relative positions in time. Thereafter the best point of co-occurrence is identified in this histogram by building a triangular weighted sum of surrounding values. This sum is shifted over the whole histogram. The time lag with the highest sum is taken as optimal (Algorithm 3). From the courses of treatment which contribute to such a cluster, the correlation values are summed up and the whole sum is normalized. This normalized sum creates the second half of our similarity score (Algorithm 4). Both halves of the score, one from the occurrences of treatments and the other from their temporal correlation, are summed together to create the overall similarity score.
Status Report
To evaluate our algorithm, we thoroughly created 62 abstract test cases. Our main focus at this time is on treatments and their corresponding pattern in time and dosage. Therefore, we just modeled the courses of treatment omitting other data such as diagnoses or demographic patient data. Those data may also determine the similarity of a medical condition and will thus be topic of future research. Starting from one standard case consisting of 8 different drugs given at different times and dosages for 10 days we developed various ways of how other cases could be different or similar with respect to treatment characteristics. We modeled for example a set of 3 interdependent drugs applied in a short period of time as it is done e.g. before cardiac catheter examinations. Then this set was altered systematically in time, dosage, and drugs in several degrees of alteration. By this we evaluated the algorithms' response to defined levels of difference. We identified twelve different categories of how cases can be similar or dissimilar (Table 1) . These categories emerge from relating new and known case to each other in a plane defined by the following two axes. One of these axes is similarity in treatment. Cases similar on this axis have a similar list of treatments that were administered to the patient. Similarity on this axis ignores chronological information. The other axis represents similarity in time and dosage patterns. Cases similar on this axis have similar patterns of administration in time and dosage. Similarity here completely omits the information to which treatments the time and dosage patterns belong. Each of the twelve categories contains a value corresponding to a medical assessment. Ideally an algorithm assigning a numerical similarity value to different cases in relation to a standard case should rate cases in accordance with the respective qualitative particular statements in Table 1 . We designed a set of five to six test cases per category with 56 having 8, 4 having 7, and 2 having 6 courses of treatment each. The algorithm was applied to these test sets. The resulting mean values of overall similarity score are shown in Table 2 . In this table, a number close to 1 means high similarity, a number closer to 0 means low. We also applied the algorithm to a case collection of 882 detailed real medical cases of patients hospitalized in internal medicine treated with an average of 10.8 (0, 72) different drugs and hospitalized for a mean length of stay of 10.2 (1, 127) days. These cases were collected in an earlier project and were used to confirm that the algorithm suitably scales up to typical size sets of real data. However, because these cases were not classified as specified in Table 1 we did not use them to calculate any ratings. For each case the similarity to all other cases in the case base was calculated. Several iterations with different thresholds for similarity were made. At each iteration, random sample checks were made to evaluate whether the classification of cases with similar ratings appeared plausible. According to this evaluation of real cases a similarity threshold of 0.7 turned out to be an adequate score to determine whether two cases are sufficiently similar or not. Setting this same threshold for similarity at 0.7 the algorithm's sensitivity on the synthetic test cases was 32/32 and the specificity was 27/30. Our algorithm needs an average of 576 milliseconds for the calculation of the similarity of one real medical case against the case base of 882 other cases. That is an average of 0.653 milliseconds per single case comparison. The computer on which this test was executed was equipped with an Intel Pentium 4 2.4 GHz processor and with 512 Mb RAM. The algorithm is implemented in Java 1.4 and run on a 1.4 runtime engine and a MS Windows 2000 operating system. The case base was preloaded from the database into Java managed objects before execution.
Lessons learned and future plans
As shown in Table 2 , our algorithm successfully produces a relatively low similarity score for cases that are completely different with respect to their pattern of time and dosage but high scores when cases are equal (score of 0.699) or similar (score of 0.528) in treatments. This proves to be as intended, although the first score is suboptimal since the mean does not show that three of five test cases are rated above our threshold of 0.7. It therefore seems that our algorithm may be open for further weight optimization on the tradeoff between treatment and time and dosage pattern. An application related problem that might arise is how to deal with standard therapies. During the course of treatment for a normal hospital stay for a specific diagnosis, many of the treatments are part of a standardized practice guideline or order set. Though the standardization in treatment plans will produce high similarity scores due to their predefined patterns of application, these are probably not associated with ADEs. Another application related problem that might arise is whether our model is capable of representing pharmacokinetics appropriately. In our test we just modeled dosing and application intervals but for a better pharmacological conclusion it would be important to model the concentration of active compounds in the body. An approximation of this could be done by calculating estimated body concentrations from the time and dosage pattern combined with some rudimentary pharmacokinetic elimination function. This data could possibly be derived from pharmacological databases enhanced by calculation of altered degradation due to impaired kidney or liver function and co-medication (drug interactions). While these are no problems inherent to the modeling itself and thus not the main concern this time they should be considered in future research to make such a system useful in a clinical setting. Our aim was to develop a case modeling and an associated similarity measurement algorithm for a CBR system that is capable of rating time-dependent data with high sensitivity and specificity. The focus of our CBR test cases was on drug therapies in which timing is an essential part of any treatment plan and which determines the ultimate (adverse) effect of pharmacotherapy. In this first step we have developed a successful model and similarity algorithm for time-value patterns with a relatively high specificity as an essential component of a CBR based alerting system for drug related events. 
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